Proprotein convertase activation of aggrecanases in cartilage in situ

被引:58
作者
Malfait, Anne-Marie [1 ]
Arner, Elizabeth C. [1 ]
Song, Ruo-Hua [1 ]
Alston, James T. [2 ]
Markosyan, Stella [3 ]
Staten, Nicholas [1 ]
Yang, Zhiyong [4 ]
Griggs, David W. [1 ]
Tortorella, Micky D. [1 ]
机构
[1] Pfizer Global Res & Dev, St Louis, MO 63017 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Abbott Labs, Libertyville, IL 60048 USA
[4] Wyeth Ayerst Res, Cambridge, MA 02140 USA
关键词
aggrecanase; ADAMTS; PACE4; proprotein convertase; cartilage; osteoarthritis; metalloproteases; post-translational activation;
D O I
10.1016/j.abb.2008.07.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Proteolytic degradation of the major cartilage macromolecules, aggrecan and type 11 collagen, is a key pathological event in osteoarthritis (OA). ADAMTS-4 and ADAMTS-5, the primary aggrecanases capable of cartilage aggrecan cleavage, are synthesized as latent enzymes and require prodomain removal for activity. The N-termini of the mature proteases suggest that activation involves a proprotein convertase, but the specific family member responsible for aggrecanase activation in cartilage in situ has not been identified. Here we describe Purification of a proprotein convertase activity from human OA Cartilage. Through biochemical characterization and the use of siRNA, PACE4 was identified as a proprotein convertase responsible for activation of aggrecanases in osteoarthritic and cytokine-stimulated cartilage. Posttranslational activation of ADAMTS-4 and ADAMTS-5 was observed in the extracellular milieu of cartilage, resulting in aggrecan degradation. These findings Suggest that PACE4 represents a novel target for the development of OA therapeutics. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:43 / 51
页数:9
相关论文
共 42 条
[1]
Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family [J].
Abbaszade, I ;
Liu, RQ ;
Yang, F ;
Rosenfeld, SA ;
Ross, OH ;
Link, JR ;
Ellis, DM ;
Tortorella, MD ;
Pratta, MA ;
Hollis, JM ;
Wynn, R ;
Duke, JL ;
George, HJ ;
Hillman, MC ;
Murphy, K ;
Wiswall, BH ;
Copeland, RA ;
Decicco, CP ;
Bruckner, R ;
Nagase, H ;
Itoh, Y ;
Newton, RC ;
Magolda, RL ;
Trzaskos, JM ;
Hollis, GF ;
Arner, EC ;
Burn, TC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (33) :23443-23450
[2]
Collins D., 1949, PATHOLOGY ARTICULAR
[3]
n-3 fatty acids specifically modulate catabolic factors involved in articular cartilage degradation [J].
Curtis, CL ;
Hughes, CE ;
Flannery, CR ;
Little, CB ;
Harwood, JL ;
Caterson, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) :721-724
[4]
IMPROVED QUANTITATION AND DISCRIMINATION OF SULFATED GLYCOSAMINOGLYCANS BY USE OF DIMETHYLMETHYLENE BLUE [J].
FARNDALE, RW ;
BUTTLE, DJ ;
BARRETT, AJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 883 (02) :173-177
[5]
Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice [J].
Glasson, SS ;
Askew, R ;
Sheppard, B ;
Carito, BA ;
Blanchet, T ;
Ma, HL ;
Flannery, CR ;
Kanki, K ;
Wang, E ;
Peluso, D ;
Yang, ZY ;
Majumdar, MK ;
Morris, EA .
ARTHRITIS AND RHEUMATISM, 2004, 50 (08) :2547-2558
[6]
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis [J].
Glasson, SS ;
Askew, R ;
Sheppard, B ;
Carito, B ;
Blanchet, T ;
Ma, HL ;
Flannery, CR ;
Peluso, D ;
Kanki, K ;
Yang, ZY ;
Majumdar, MK ;
Morris, EA .
NATURE, 2005, 434 (7033) :644-648
[7]
SOME BIOCHEMICAL AND BIOPHYSICAL PARAMETERS FOR THE STUDY OF THE PATHOGENESIS OF OSTEO-ARTHRITIS - A COMPARISON BETWEEN THE PROCESSES OF AGING AND DEGENERATION IN HUMAN HIP CARTILAGE [J].
GRUSHKO, G ;
SCHNEIDERMAN, R ;
MAROUDAS, A .
CONNECTIVE TISSUE RESEARCH, 1989, 19 (2-4) :149-176
[8]
MONOCLONAL-ANTIBODIES THAT SPECIFICALLY RECOGNIZE NEOEPITOPE SEQUENCES GENERATED BY AGGRECANASE AND MATRIX METALLOPROTEINASE CLEAVAGE OF AGGRECAN - APPLICATION TO CATABOLISM IN-SITU AND IN-VITRO [J].
HUGHES, CE ;
CATERSON, B ;
FOSANG, AJ ;
ROUGHLEY, PJ ;
MORT, JS .
BIOCHEMICAL JOURNAL, 1995, 305 :799-804
[9]
α1-antitrypsin Portland, a bioengineered serpin highly selective for furin:: Application as an antipathogenic agent [J].
Jean, F ;
Stella, K ;
Thomas, L ;
Liu, GP ;
Xiang, Y ;
Reason, AJ ;
Thomas, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) :7293-7298
[10]
Cell-surface processing of pro-ADAMTS9 by furin [J].
Koo, BH ;
Longpré, JM ;
Somerville, RPT ;
Alexander, JP ;
Leduc, R ;
Apteo, SS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (18) :12485-12494